Leukeima, Lymphoma, Histiocytoses Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL): Overview and introduction to the proceedings of the 2016 TACL investigator meeting
Alan S. Wayne, Erika Shin-Kashiyama, Richard Sposto & Paul Gaynon
Pages: 349-354 | DOI: 10.1080/08880018.2017.1377329
Investigating the biology of relapsed acute leukemia: Proceedings of the Therapeutic Advances for Childhood Leukemia & Lymphoma (TACL) Consortium Biology Working Group
Deepa Bhojwani, Michael J. Burke, Terzah Horton, David S. Ziegler, Maria Luisa Sulis, Kirk R. Schultz, Alan Wayne, Shai Izraeli & Bill H. Chang
Pages: 355-364 | DOI: 10.1080/08880018.2017.1395937
Understanding the bone marrow microenvironment in hematologic malignancies: A focus on chemokine, integrin, and extracellular vesicle signaling
Edward Allan Racela Sison MD, Peter Kurre MD & Yong-Mi Kim MD, PhD
Pages: 365-378 | DOI: 10.1080/08880018.2017.1395938
Checkpoint inhibition in pediatric hematologic malignancies
Kara L. Davis, Archana M. Agarwal & Anupam R. Verma
Pages: 379-394 | DOI: 10.1080/08880018.2017.1383542
Redefining treatment failure for pediatric acute leukemia in the era of minimal residual disease testing
Van Huynh MD, Theodore W. Laetsch MD, Reuven J. Schore MD, Paul Gaynon MD & Maureen M. O'Brien MD, MS
Pages: 395-408 | DOI: 10.1080/08880018.2017.1397073
TACL'ing supportive care needs in pediatric early phase clinical trials for acute leukemia: A report from the therapeutic advances in childhood leukemia & lymphoma (TACL) consortium supportive care committee
E Orgel & J J Auletta
Pages: 409-417 | DOI: 10.1080/08880018.2017.1395936
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου